Related Experiment Video
Updated: Jun 2, 2026
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Asymptomatic tuberculosis in Japan: a 15-year national surveillance study, 2008-2022
Tomohiko Ukai1, Kaung Si Thu1, Kazuhiro Uchimura1
1Department of Epidemiology and Clinical Research, The Research Institute of Tuberculosis, Tokyo, Japan.
Background:
Asymptomatic tuberculosis (TB), defined as active TB without reported symptoms, remains poorly characterised. We assessed long-term trends, factors associated with asymptomatic diagnosis, and treatment outcomes of asymptomatic TB in Japan using nationwide surveillance data with widespread chest radiographic screening.
Methods:
We analysed bacteriologically confirmed pulmonary TB cases reported to the Japan Tuberculosis Surveillance System between 2008 and 2022. Patients were classified as asymptomatic, respiratory symptomatic, or non-respiratory symptomatic TB. Trends in symptom status were assessed. Factors associated with asymptomatic diagnosis and mortality during treatment were evaluated using modified Poisson regression with cluster-robust standard errors among cases notified during 2017-2022, when key covariates were consistently available.
Findings:
Among 141,481 pulmonary TB cases, 20.2% were asymptomatic, 61.3% had respiratory symptoms, and 18.5% had non-respiratory symptoms. Over time, the proportion of asymptomatic TB increased slightly, remaining around one-fifth of all pulmonary TB cases and 12-15% of cases with smear-positive or cavitary disease. Among asymptomatic patients, 34.1% were smear positive and 20.3% had cavitary disease. In multivariable analysis, asymptomatic TB was more common in younger groups, those in employment or education, and those with previous TB treatment. Mortality during treatment was lower in asymptomatic TB (adjusted risk ratio 0.57, 95% CI 0.54-0.60) than in respiratory symptomatic TB.
Interpretation:
Asymptomatic TB represents a substantial and persistent component of the TB burden in Japan, including potentially infectious cases. Reliance on symptom-based case detection alone may miss a considerable proportion of TB, supporting the need for targeted screening and earlier diagnosis.
Funding:
Research Institute of Tuberculosis (general research funds).
Related Concept Videos
01:28Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:23Tuberculosis
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:31Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...